Could Swiss pharmaceutical company Roche’s late-stage antibiotic trials signal new hope against antibiotic‐resistant pathogens? On this special REPLAY episode (originally aired August 2024), we take a deep dive into the state of antimicrobial resistance, from hospital wards to farm fields. As these microscopic threats drive up healthcare costs, jeopardize food security, and reshape insurance risk worldwide, understanding the crisis has never been more critical. But while the need to act is clear, the solutions remain complex. In this episode, we examine whether there’s a compelling investment case for fighting back, and what that could mean for the future of global health.

Host: Bentley Kaplan

Guest: Namita Nair